153 related articles for article (PubMed ID: 30801959)
1. The impact of human CES1 genetic variation on enzyme activity assessed by ritalinic acid/methylphenidate ratios.
Stage C; Dalhoff K; Rasmussen HB; Schow Guski L; Thomsen R; Bjerre D; Ferrero-Miliani L; Busk Madsen M; Jürgens G
Basic Clin Pharmacol Toxicol; 2019 Jul; 125(1):54-61. PubMed ID: 30801959
[TBL] [Abstract][Full Text] [Related]
2. The impact of CES1 genotypes on the pharmacokinetics of methylphenidate in healthy Danish subjects.
Stage C; Jürgens G; Guski LS; Thomsen R; Bjerre D; Ferrero-Miliani L; Lyauk YK; Rasmussen HB; Dalhoff K;
Br J Clin Pharmacol; 2017 Jul; 83(7):1506-1514. PubMed ID: 28087982
[TBL] [Abstract][Full Text] [Related]
3. Methylphenidate side effect profile is influenced by genetic variation in the attention-deficit/hyperactivity disorder-associated CES1 gene.
Johnson KA; Barry E; Lambert D; Fitzgerald M; McNicholas F; Kirley A; Gill M; Bellgrove MA; Hawi Z
J Child Adolesc Psychopharmacol; 2013 Dec; 23(10):655-64. PubMed ID: 24350812
[TBL] [Abstract][Full Text] [Related]
4. Physiologically-Based Pharmacokinetic Modeling to Predict Methylphenidate Exposure Affected by Interplay Among Carboxylesterase 1 Pharmacogenetics, Drug-Drug Interactions, and Sex.
Xiao J; Shi J; Thompson BR; Smith DE; Zhang T; Zhu HJ
J Pharm Sci; 2022 Sep; 111(9):2606-2613. PubMed ID: 35526575
[TBL] [Abstract][Full Text] [Related]
5. Effect of carboxylesterase 1 c.428G > A single nucleotide variation on the pharmacokinetics of quinapril and enalapril.
Tarkiainen EK; Tornio A; Holmberg MT; Launiainen T; Neuvonen PJ; Backman JT; Niemi M
Br J Clin Pharmacol; 2015 Nov; 80(5):1131-8. PubMed ID: 25919042
[TBL] [Abstract][Full Text] [Related]
6. Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis.
Zhu HJ; Patrick KS; Yuan HJ; Wang JS; Donovan JL; DeVane CL; Malcolm R; Johnson JA; Youngblood GL; Sweet DH; Langaee TY; Markowitz JS
Am J Hum Genet; 2008 Jun; 82(6):1241-8. PubMed ID: 18485328
[TBL] [Abstract][Full Text] [Related]
7. Dabigatran etexilate activation is affected by the CES1 genetic polymorphism G143E (rs71647871) and gender.
Shi J; Wang X; Nguyen JH; Bleske BE; Liang Y; Liu L; Zhu HJ
Biochem Pharmacol; 2016 Nov; 119():76-84. PubMed ID: 27614009
[TBL] [Abstract][Full Text] [Related]
8. High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder: A Case Series.
Westerkamp AC; Pereira RR; Huitema VR; Kouwert EAM; Matic M; van Schaik RHN; Punt N; Schoevers RA; Touw DJ
J Clin Psychopharmacol; 2024 Jan-Feb 01; 44(1):35-38. PubMed ID: 37851403
[TBL] [Abstract][Full Text] [Related]
9. Plasma concentrations of methylphenidate enantiomers in adults with ADHD and substance use disorder, with focus on high doses and relationship to carboxylesterase activity.
Arvidsson M; Franck J; Ackehed G; Pettersson Bergstrand M; Ekström L; Rosenborg S; Dahl ML
Basic Clin Pharmacol Toxicol; 2022 Apr; 130(4):492-500. PubMed ID: 35040257
[TBL] [Abstract][Full Text] [Related]
10. Population Pharmacokinetics of Methylphenidate in Healthy Adults Emphasizing Novel and Known Effects of Several Carboxylesterase 1 (CES1) Variants.
Lyauk YK; Stage C; Bergmann TK; Ferrero-Milliani L; Bjerre D; Thomsen R; Dalhoff KP; Rasmussen HB; Jürgens G
Clin Transl Sci; 2016 Dec; 9(6):337-345. PubMed ID: 27754602
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of methylphenidate and ritalinic acid in plasma correlations with exhaled breath and oral fluid in healthy volunteers.
Arvidsson M; Dahl ML; Beck O; Ackehed G; Nordin K; Rosenborg S
Eur J Clin Pharmacol; 2020 Feb; 76(2):229-237. PubMed ID: 31786618
[TBL] [Abstract][Full Text] [Related]
12. The Pharmacokinetics of Enalapril in Relation to CES1 Genotype in Healthy Danish Volunteers.
Stage C; Jürgens G; Guski LS; Thomsen R; Bjerre D; Ferrero-Miliani L; Lyauk YK; Rasmussen HB; Dalhoff K;
Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):487-492. PubMed ID: 28639420
[TBL] [Abstract][Full Text] [Related]
13. A simple allele-specific polymerase chain reaction method to detect the Gly143Glu polymorphism in the human carboxylesterase 1 gene: importance of genotyping for pharmacogenetic treatment.
Walter Soria N; Belaus A; Galván C; Ana Pasquali M; Velez P; Del Carmen Montes C; Beltramo DM
Genet Test Mol Biomarkers; 2010 Dec; 14(6):749-51. PubMed ID: 20858053
[TBL] [Abstract][Full Text] [Related]
14. Impact of carboxylesterase 1 genetic polymorphism on trandolapril activation in human liver and the pharmacokinetics and pharmacodynamics in healthy volunteers.
Wang X; Her L; Xiao J; Shi J; Wu AH; Bleske BE; Zhu HJ
Clin Transl Sci; 2021 Jul; 14(4):1380-1389. PubMed ID: 33660934
[TBL] [Abstract][Full Text] [Related]
15. Identification of selected therapeutic agents as inhibitors of carboxylesterase 1: potential sources of metabolic drug interactions.
Zhu HJ; Appel DI; Peterson YK; Wang Z; Markowitz JS
Toxicology; 2010 Apr; 270(2-3):59-65. PubMed ID: 20097249
[TBL] [Abstract][Full Text] [Related]
16. Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators.
Her L; Zhu HJ
Drug Metab Dispos; 2020 Mar; 48(3):230-244. PubMed ID: 31871135
[TBL] [Abstract][Full Text] [Related]
17. Carboxylesterase 1 gene polymorphism and methylphenidate response in ADHD.
Nemoda Z; Angyal N; Tarnok Z; Gadoros J; Sasvari-Szekely M
Neuropharmacology; 2009 Dec; 57(7-8):731-3. PubMed ID: 19733552
[TBL] [Abstract][Full Text] [Related]
18. Effect of CES1 genetic variation on enalapril steady-state pharmacokinetics and pharmacodynamics in healthy subjects.
Her LH; Wang X; Shi J; Choi HJ; Jung SM; Smith LS; Wu AH; Bleske BE; Zhu HJ
Br J Clin Pharmacol; 2021 Dec; 87(12):4691-4700. PubMed ID: 33963573
[TBL] [Abstract][Full Text] [Related]
19. Relative Bioavailability of Methylphenidate Extended-release Chewable Tablets Chewed Versus Swallowed Whole.
Abbas R; Childress AC; Nagraj P; Rolke R; Berry SA; Palumbo DR
Clin Ther; 2018 May; 40(5):733-740. PubMed ID: 29703430
[TBL] [Abstract][Full Text] [Related]
20. A single-dose, two-way crossover, bioequivalence study of dexmethylphenidate HCl with and without food in healthy subjects.
Teo SK; Scheffler MR; Wu A; Stirling DI; Thomas SD; Stypinski D; Khetani VD
J Clin Pharmacol; 2004 Feb; 44(2):173-8. PubMed ID: 14747426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
